Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Bladder Cancer

  Free Subscription


26.08.2019

1 Aging (Albany NY)
1 Antioxidants (Basel)
2 Beijing Da Xue Xue Bao Yi Xue Ban
1 Biosci Rep
2 BJU Int
1 BMC Urol
1 Cancer Causes Control
1 Cancer Manag Res
1 Cancers (Basel)
1 Case Rep Oncol
1 Diagn Pathol
1 EBioMedicine
2 Eur Urol
1 Eur Urol Focus
2 Int J Cancer
1 Int J Environ Res Public Health
1 J BUON
1 J Cancer
1 J Endourol
1 J Med Microbiol
1 J Patient Rep Outcomes
1 J Urol
1 Klin Onkol
1 Minerva Urol Nefrol
1 Nat Rev Urol
1 Oncol Lett
1 Oncol Rep
2 Pathologe
1 Phytomedicine
1 Urol Case Rep
1 Urol Oncol
1 Urology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Aging (Albany NY)

  1. HE A, He S, Peng D, Zhan Y, et al
    Prognostic value of long non-coding RNA signatures in bladder cancer.
    Aging (Albany NY). 2019;11.
    PubMed     Text format     Abstract available


    Antioxidants (Basel)

  2. PARK C, Cha HJ, Lee H, Hwang-Bo H, et al
    Induction of G2/M Cell Cycle Arrest and Apoptosis by Genistein in Human Bladder Cancer T24 Cells through Inhibition of the ROS-Dependent PI3k/Akt Signal Transduction Pathway.
    Antioxidants (Basel). 2019;8.
    PubMed     Text format     Abstract available


    Beijing Da Xue Xue Bao Yi Xue Ban

  3. HUANG HW, Yan B, Shang MX, Liu LB, et al
    [Propensity-matched comparison of laparoscopic and open radical cystectomy for female patients with bladder cancer].
    Beijing Da Xue Xue Bao Yi Xue Ban. 2019;51:698-705.
    PubMed     Text format     Abstract available

  4. YANG FL, Hong K, Zhao GJ, Liu C, et al
    [Construction of prognostic model and identification of prognostic biomarkers based on the expression of long non-coding RNA in bladder cancer via bioinformatics].
    Beijing Da Xue Xue Bao Yi Xue Ban. 2019;51:615-622.
    PubMed     Text format     Abstract available


    Biosci Rep

  5. JI M, Wang Z, Chen J, Gu L, et al
    Up-regulated ENO1 promotes the bladder cancer cell growth and proliferation via regulating beta-catenin.
    Biosci Rep. 2019 Aug 20. pii: BSR20190503. doi: 10.1042/BSR20190503.
    PubMed     Text format     Abstract available


    BJU Int

  6. TAN WS, Sarpong R, Khetrapal P, Rodney S, et al
    Does urinary cytology have a role in haematuria investigations?
    BJU Int. 2019;123:74-81.
    PubMed     Text format     Abstract available

  7. JAIN RK, Grivas P, Pal SK
    Non-invasive diagnosis and monitoring of urothelial bladder cancer: are we there yet?
    BJU Int. 2019;124:361-362.
    PubMed     Text format    


    BMC Urol

  8. SHARMA M, Goto T, Yang Z, Miyamoto H, et al
    The impact of perivesical lymph node metastasis on clinical outcomes of bladder cancer patients undergoing radical cystectomy.
    BMC Urol. 2019;19:77.
    PubMed     Text format     Abstract available


    Cancer Causes Control

  9. LIM J, Kang SY, Park HS
    Low serum cholesterol as a risk factor for kidney and bladder cancer among Korean men: using a national cohort sample.
    Cancer Causes Control. 2019 Aug 20. pii: 10.1007/s10552-019-01219.
    PubMed     Text format    


    Cancer Manag Res

  10. ZOU J, Huang R, Li H, Wang B, et al
    Secreted TGF-beta-induced protein promotes aggressive progression in bladder cancer cells.
    Cancer Manag Res. 2019;11:6995-7006.
    PubMed     Text format     Abstract available


    Cancers (Basel)

  11. GATTA LB, Melocchi L, Bugatti M, Missale F, et al
    Hyper-Activation of STAT3 Sustains Progression of Non-Papillary Basal-Type Bladder Cancer via FOSL1 Regulome.
    Cancers (Basel). 2019;11.
    PubMed     Text format     Abstract available


    Case Rep Oncol

  12. KAWAHARA T, Takamoto D, Miyoshi Y, Yao M, et al
    Inserting a Metallic Ureteral Stent Using an Antegrade Approach Freed a Patient from Nephrostomy Created due to Hydronephrosis Caused by Bladder Cancer.
    Case Rep Oncol. 2019;12:560-563.
    PubMed     Text format     Abstract available


    Diagn Pathol

  13. JANSEN I, Lucas M, Savci-Heijink CD, Meijer SL, et al
    Three-dimensional histopathological reconstruction of bladder tumours.
    Diagn Pathol. 2019;14:25.
    PubMed     Text format     Abstract available


    EBioMedicine

  14. CHEN Z, He S, Zhan Y, He A, et al
    TGF-beta-induced transgelin promotes bladder cancer metastasis by regulating epithelial-mesenchymal transition and invadopodia formation.
    EBioMedicine. 2019 Aug 13. pii: S2352-3964(19)30528.
    PubMed     Text format     Abstract available


    Eur Urol

  15. LU M, Zhang Y, Xiao Y
    Re: Kimmo Kettunen, Peter J. Bostrom, Tarja Lamminen, et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.06.016.
    Eur Urol. 2019 Aug 13. pii: S0302-2838(19)30605.
    PubMed     Text format    

  16. KETTUNEN K, Bostrom PJ, Taimen P
    Reply to Mengxin Lu, Yi Zhang, Yu Xiao's Letter to the Editor, re: Kimmo Kettunen, Peter J. Bostrom, Tarja Lamminen, et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol. In
    Eur Urol. 2019 Aug 13. pii: S0302-2838(19)30610.
    PubMed     Text format    


    Eur Urol Focus

  17. HECK MM, Gschwend JE
    Extended Lymph Node Dissection for Bladder Cancer: Do Clinical Trials Rule Out a Benefit?
    Eur Urol Focus. 2019 Aug 19. pii: S2405-4569(19)30212.
    PubMed     Text format     Abstract available


    Int J Cancer

  18. TURNER MC, Gracia-Lavedan E, Cirac M, Castano-Vinyals G, et al
    Reply to: Air pollution and incident bladder cancer: a risk assessment.
    Int J Cancer. 2019 Aug 19. doi: 10.1002/ijc.32632.
    PubMed     Text format    

  19. KAWADA T
    Air pollution and incident bladder cancer: a risk assessment.
    Int J Cancer. 2019 Aug 19. doi: 10.1002/ijc.32633.
    PubMed     Text format    


    Int J Environ Res Public Health

  20. YANG PJ, Hsieh MJ, Hung TW, Wang SS, et al
    Effects of Long Noncoding RNA H19 Polymorphisms on Urothelial Cell Carcinoma Development.
    Int J Environ Res Public Health. 2019;16.
    PubMed     Text format     Abstract available


    J BUON

  21. HUANG Z, Liu G
    Research on correlations of MiR-203 expression with onset and prognosis of bladder cancer.
    J BUON. 2019;24:1210-1218.
    PubMed     Text format     Abstract available


    J Cancer

  22. ZHU CZ, Ting HN, Ng KH, Ong TA, et al
    A review on the accuracy of bladder cancer detection methods.
    J Cancer. 2019;10:4038-4044.
    PubMed     Text format     Abstract available


    J Endourol

  23. DARRAD MP, Syed J, Ahmed Z, Syed HA, et al
    Long-Term Prospective Outcomes Of Patients With Non-Muscle Invasive Bladder Cancer Following Holmium Laser Ablation.
    J Endourol. 2019 Aug 21. doi: 10.1089/end.2019.0253.
    PubMed     Text format     Abstract available


    J Med Microbiol

  24. BI H, Tian Y, Song C, Li J, et al
    Urinary microbiota - a potential biomarker and therapeutic target for bladder cancer.
    J Med Microbiol. 2019 Aug 16. doi: 10.1099/jmm.0.001058.
    PubMed     Text format     Abstract available


    J Patient Rep Outcomes

  25. TAARNHOJ GA, Lindberg H, Johansen C, Pappot H, et al
    Patient-reported outcomes item selection for bladder cancer patients in chemo- or immunotherapy.
    J Patient Rep Outcomes. 2019;3:56.
    PubMed     Text format     Abstract available


    J Urol

  26. LAGUNA MP
    Re: Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial Carcinoma.
    J Urol. 2019;202:456-457.
    PubMed     Text format    


    Klin Onkol

  27. ABDOLMALEKI F, Ghafouri-Fard S, Taheri M, Omrani DM, et al
    P21-Associated ncRNA DNA Damage-Activated Expression in Bladder Cancer.
    Klin Onkol. 2019;32:277-280.
    PubMed     Text format     Abstract available


    Minerva Urol Nefrol

  28. MURALI-KRISHNAN S, Pang KH, Greco F, Fiori C, et al
    Bladder-sparing treatment in MIBC: where do we stand?
    Minerva Urol Nefrol. 2019;71:101-112.
    PubMed     Text format     Abstract available


    Nat Rev Urol

  29. JOICE GA, Bivalacqua TJ, Kates M
    Optimizing pharmacokinetics of intravesical chemotherapy for bladder cancer.
    Nat Rev Urol. 2019 Aug 21. pii: 10.1038/s41585-019-0220.
    PubMed     Text format     Abstract available


    Oncol Lett

  30. REN Y, Zhao C, He Y, Xu H, et al
    Long non-coding RNA bladder cancer-associated transcript 2 contributes to disease progression, chemoresistance and poor survival of patients with colorectal cancer.
    Oncol Lett. 2019;18:2050-2058.
    PubMed     Text format     Abstract available


    Oncol Rep

  31. LI F, Guo H, Yang Y, Feng M, et al
    Autophagy modulation in bladder cancer development and treatment (Review).
    Oncol Rep. 2019 Aug 21. doi: 10.3892/or.2019.7286.
    PubMed     Text format     Abstract available


    Pathologe

  32. REIS H, Szarvas T, Grunwald V
    [Predictive biomarkers in oncologic uropathology].
    Pathologe. 2019;40:264-275.
    PubMed     Text format     Abstract available

  33. REIS H, Szarvas T
    Urachal cancer-current concepts of a rare cancer.
    Pathologe. 2019;40.
    PubMed     Text format     Abstract available


    Phytomedicine

  34. SHIN SS, Park YJ, Hwang B, Park SL, et al
    Triacanthine exerts antitumor effects on bladder cancer in vitro and in vivo.
    Phytomedicine. 2019;64:153069.
    PubMed     Text format     Abstract available


    Urol Case Rep

  35. BURITY CRT, Ferreira FT, Veiga AF, Saade RD, et al
    Advanced small-cell bladder cancer into a ureterocele: A case report and literature review.
    Urol Case Rep. 2019;27:100986.
    PubMed     Text format     Abstract available


    Urol Oncol

  36. CHEN FV, Koru-Sengul T, Miao F, Jue JS, et al
    Propensity-matched analysis of stage-specific efficacy of adjuvant chemotherapy for bladder cancer.
    Urol Oncol. 2019 Aug 14. pii: S1078-1439(19)30251.
    PubMed     Text format     Abstract available


    Urology

  37. LIN-BRANDE M, Pearce SM, Ashrafi AN, Nazemi A, et al
    Assessing the Impact of Time to Cystectomy for Variant Histology of Urothelial Bladder Cancer.
    Urology. 2019 Aug 14. pii: S0090-4295(19)30721.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: